Fundz
Every executive departure read straight from the 8-K, filtered to the company size you serve, the morning it lands.See it live →

Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer

PRIVATESep 17, 2026•about 2 hours ago

Position

Chief Financial Officer

Company

Cyllene Therapeutics

Marc Grasso
ParisBiotechnologyHealth CareTherapeutics

Description

Cyllene Therapeutics has announced the appointment of Dr. Marc Grasso as Executive Vice-President and Chief Financial Officer. Dr

Company Information

Company

Cyllene Therapeutics

Location

Paris, Ile-de-France, France

About

Cyllene Therapeutics, formerly known as EG 427, is a clinical-stage biotechnology company focused on the development of precision genetic medicines for neurological diseases. The company is known for its HERMES technology, which facilitates safe and targeted delivery of therapeutic DNA. Cyllene Tx aims to advance its lead candidate, EG110A, for chronic indications in neuro-urology. The company has garnered significant funding to support its clinical development and pipeline expansion.

Don't miss Cyllene Therapeutics's next move

Get an email the moment Cyllene Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Cyllene Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Cyllene Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.